{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:35:55Z","timestamp":1791916555520,"version":"4.3.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,3,5]],"date-time":"2012-03-05T00:00:00Z","timestamp":1330905600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1038\/aps.2012.9","type":"journal-article","created":{"date-parts":[[2012,3,5]],"date-time":"2012-03-05T15:02:32Z","timestamp":1330959752000},"page":"551-557","source":"Crossref","is-referenced-by-count":45,"title":["Imatinib induces H2AX phosphorylation and apoptosis in chronic myelogenous leukemia cells in vitro via caspase-3\/Mst1 pathway"],"prefix":"10.1038","volume":"33","author":[{"given":"Yan-jun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-rong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-feng","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian-ning","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,3,5]]},"reference":[{"key":"BFaps20129_CR1","doi-asserted-by":"publisher","first-page":"5489","DOI":"10.1158\/0008-5472.CAN-07-0302","volume":"67","author":"KM Brauer","year":"2007","unstructured":"Brauer KM, Werth D, von Schwarzenberg K, Bringmann A, Kanz L, Grunebach F, et al. BCR-ABL activity is critical for the immunogenicity of chronic myelogenous leukemia cells. Cancer Res 2007; 67: 5489\u201397.","journal-title":"Cancer Res"},{"key":"BFaps20129_CR2","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMra020777","volume":"349","author":"JM Goldman","year":"2003","unstructured":"Goldman JM, Melo JV . Chronic myeloid leukemia \u2014 advances in biology and new approaches to treatment. N Engl J Med 2003; 349: 1451\u201364.","journal-title":"N Engl J Med"},{"key":"BFaps20129_CR3","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1056\/NEJM200104053441409","volume":"344","author":"JM Goldman","year":"2001","unstructured":"Goldman JM, Melo JV . Targeting the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001; 344: 1084\u20136.","journal-title":"N Engl J Med"},{"key":"BFaps20129_CR4","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1182\/blood-2005-12-040972","volume":"109","author":"C Yoshida","year":"2007","unstructured":"Yoshida C, Yoshida F, Sears DE, Hart SM, Ikebe D, Muto A, et al. Bcr-Abl signaling through the PI-3\/S6 kinase pathway inhibits nuclear translocation of the transcription factor Bach2, which represses the antiapoptotic factor heme oxygenase-1. Blood 2007; 109: 1211\u20139.","journal-title":"Blood"},{"key":"BFaps20129_CR5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ccr.2009.08.012","volume":"16","author":"MP Strout","year":"2009","unstructured":"Strout MP, Schatz DG . Imatinib resistance and progression of CML to blast crisis: somatic hypermutation AIDing the way. Cancer Cell 2009; 16: 174\u20136.","journal-title":"Cancer Cell"},{"key":"BFaps20129_CR6","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1476-4598-9-112","volume":"9","author":"Z Lu","year":"2010","unstructured":"Lu Z, Jin Y, Chen C, Li J, Cao Q, Pan J . Pristimerin induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation by blocking NF-kappaB signaling and depleting Bcr-Abl. Mol Cancer 2010; 9: 112.","journal-title":"Mol Cancer"},{"key":"BFaps20129_CR7","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.leukres.2007.11.008","volume":"32","author":"Y Deguchi","year":"2008","unstructured":"Deguchi Y, Kimura S, Ashihara E, Niwa T, Hodohara K, Fujiyama Y, et al. Comparison of imatinib, dasatinib, nilotinib and INNO-406 in imatinib-resistant cell lines. Leuk Res 2008; 32: 980\u20133.","journal-title":"Leuk Res"},{"key":"BFaps20129_CR8","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.1074\/jbc.273.10.5858","volume":"273","author":"EP Rogakou","year":"1998","unstructured":"Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM . DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998; 273: 5858\u201368.","journal-title":"J Biol Chem"},{"key":"BFaps20129_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.molcel.2006.05.023","volume":"23","author":"C Lu","year":"2006","unstructured":"Lu C, Zhu F, Cho YY, Tang F, Zykova T, Ma WY, et al. Cell apoptosis: requirement of H2AX in DNA ladder formation, but not for the activation of caspase-3. Mol Cell 2006; 23: 121\u201332.","journal-title":"Mol Cell"},{"key":"BFaps20129_CR10","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1016\/j.febslet.2008.06.051","volume":"582","author":"C Lu","year":"2008","unstructured":"Lu C, Shi Y, Wang Z, Song Z, Zhu M, Cai Q, et al. Serum starvation induces H2AX phosphorylation to regulate apoptosis via p38 MAPK pathway. FEBS Lett 2008; 582: 2703\u20138.","journal-title":"FEBS Lett"},{"key":"BFaps20129_CR11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0092-8674(00)00118-5","volume":"103","author":"P Cheung","year":"2000","unstructured":"Cheung P, Allis CD, Sassone-Corsi P . Signaling to chromatin through histone modifications. Cell 2000; 103: 263\u201371.","journal-title":"Cell"},{"key":"BFaps20129_CR12","doi-asserted-by":"publisher","first-page":"42462","DOI":"10.1074\/jbc.C100466200","volume":"276","author":"S Burma","year":"2001","unstructured":"Burma S, Chen BP, Murphy M, Kurimasa A, Chen DJ . ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J Biol Chem 2001; 276: 42462\u20137.","journal-title":"J Biol Chem"},{"key":"BFaps20129_CR13","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nature07849","volume":"458","author":"PJ Cook","year":"2009","unstructured":"Cook PJ, Ju BG, Telese F, Wang X, Glass CK, Rosenfeld MG . Tyrosine dephosphorylation of H2AX modulates apoptosis and survival decisions. Nature 2009; 458: 591\u20136.","journal-title":"Nature"},{"key":"BFaps20129_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature07668","volume":"457","author":"A Xiao","year":"2009","unstructured":"Xiao A, Li H, Shechter D, Ahn SH, Fabrizio LA, Erdjument-Bromage H, et al. WSTF regulates the H2AX DNA damage response via a novel tyrosine kinase activity. Nature 2009; 457: 57\u201362.","journal-title":"Nature"},{"key":"BFaps20129_CR15","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1158\/1055-9965.EPI-06-0639","volume":"16","author":"KL Novik","year":"2007","unstructured":"Novik KL, Spinelli JJ, Macarthur AC, Shumansky K, Sipahimalani P, Leach S, et al. Genetic variation in H2AFX contributes to risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2007; 16: 1098\u2013106.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFaps20129_CR16","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1158\/0008-5472.CAN-06-3497","volume":"67","author":"Y Liu","year":"2007","unstructured":"Liu Y, Tseng M, Perdreau SA, Rossi F, Antonescu C, Besmer P, et al. Histone H2AX is a mediator of gastrointestinal stromal tumor cell apoptosis following treatment with imatinib mesylate. Cancer Res 2007; 67: 2685\u201392.","journal-title":"Cancer Res"},{"key":"BFaps20129_CR17","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/nrc2523","volume":"8","author":"WM Bonner","year":"2008","unstructured":"Bonner WM, Redon CE, Dickey JS, Nakamura AJ, Sedelnikova OA, Solier S, et al. \u03b3H2AX and cancer. Nat Rev Cancer 2008; 8: 957\u201367.","journal-title":"Nat Rev Cancer"},{"key":"BFaps20129_CR18","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1111\/j.1349-7006.2009.01172.x","volume":"100","author":"A Nagamachi","year":"2009","unstructured":"Nagamachi A, Yamasaki N, Miyazaki K, Oda H, Miyazaki M, Honda Z . et al. Haploinsufficiency and acquired loss of Bcl11b and H2AX induces blast crisis of chronic myelogenous leukemia in a transgenic mouse model. Cancer Sci 2009; 100: 1219\u201326.","journal-title":"Cancer Sci"},{"key":"BFaps20129_CR19","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1096\/fj.03-0322","volume":"17","author":"A Jacquel","year":"2003","unstructured":"Jacquel A, Herrant M, Legros L, Belhacene N, Luciano F, Pages G, et al. Imatinib induces mitochondria-dependent apoptosis of the Bcr-Abl-positive K562 cell line and its differentiation toward the erythroid lineage. FASEB J 2003; 17: 2160\u20132.","journal-title":"FASEB J"},{"key":"BFaps20129_CR20","doi-asserted-by":"publisher","first-page":"4112","DOI":"10.1158\/0008-5472.CAN-09-4244","volume":"70","author":"H Cha","year":"2010","unstructured":"Cha H, Lowe JM, Li H, Lee JS, Belova GI, Bulavin DV, et al. Wip1 directly dephosphorylates gamma-H2AX and attenuates the DNA damage response. Cancer Res 2010; 70: 4112\u201322.","journal-title":"Cancer Res"},{"key":"BFaps20129_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1476-4598-7-61","volume":"7","author":"Y Liu","year":"2008","unstructured":"Liu Y, Parry JA, Chin A, Duensing S, Duensing A . Soluble histone H2AX is induced by DNA replication stress and sensitizes cells to undergo apoptosis. Mol Cancer 2008; 7: 61.","journal-title":"Mol Cancer"},{"key":"BFaps20129_CR22","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1016\/S0092-8674(04)00031-5","volume":"116","author":"P Li","year":"2004","unstructured":"Li P, Nijhawan D, Wang X . Mitochondrial activation of apoptosis. Cell 2004; 116: S57\u20139.","journal-title":"Cell"},{"key":"BFaps20129_CR23","doi-asserted-by":"publisher","first-page":"39108","DOI":"10.1074\/jbc.M110.151753","volume":"285","author":"W Wen","year":"2010","unstructured":"Wen W, Zhu F, Zhang J, Keum YS, Zykova T, Yao K, et al. MST1 promotes apoptosis through phosphorylation of histone H2AX. J Biol Chem 2010; 285: 39108\u201316.","journal-title":"J Biol Chem"},{"key":"BFaps20129_CR24","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/onc.2009.501","volume":"29","author":"L Macurek","year":"2010","unstructured":"Macurek L, Lindqvist A, Voets O, Kool J, Vos HR, Medema RH . Wip1 phosphatase is associated with chromatin and dephosphorylates gammaH2AX to promote checkpoint inhibition. Oncogene 2010; 29: 2281\u201391.","journal-title":"Oncogene"},{"key":"BFaps20129_CR25","doi-asserted-by":"publisher","first-page":"12935","DOI":"10.1074\/jbc.M109.071696","volume":"285","author":"SH Moon","year":"2010","unstructured":"Moon SH, Lin L, Zhang X, Nguyen TA, Darlington Y, Waldman AS, et al. Wildtype p53-induced phosphatase 1 dephosphorylates histone variant \u03b3-H2AX and suppresses DNA double strand break repair. J Biol Chem 2010; 285: 12935\u201347.","journal-title":"J Biol Chem"},{"key":"BFaps20129_CR26","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","volume":"128","author":"T Kouzarides","year":"2007","unstructured":"Kouzarides T . Chromatin modifications and their function. Cell 2007; 128: 693\u2013705.","journal-title":"Cell"},{"key":"BFaps20129_CR27","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1158\/0008-5472.CAN-10-2012","volume":"71","author":"F Zhu","year":"2011","unstructured":"Zhu F, Zykova TA, Peng C, Zhang J, Cho YY, Zheng D, et al. Phosphorylation of H2AX at Ser139 and a new phosphorylation site Ser16 by RSK2 decreases H2AX ubiquitination and inhibits cell transformation. Cancer Res 2011; 71: 393\u2013403.","journal-title":"Cancer Res"},{"key":"BFaps20129_CR28","doi-asserted-by":"publisher","first-page":"30806","DOI":"10.1074\/jbc.M111.257469","volume":"286","author":"CY Wu","year":"2011","unstructured":"Wu CY, Kang HY, Yang WL, Wu J, Jeong YS, Wang J, et al. Critical role of monoubiquitination of histone H2AX protein in histone H2AX phosphorylation and DNA damage response. J Biol Chem 2011; 286: 30806\u201315.","journal-title":"J Biol Chem"},{"key":"BFaps20129_CR29","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ccr.2009.07.030","volume":"16","author":"L Klemm","year":"2009","unstructured":"Klemm L, Duy C, Iacobucci I, Kuchen S, von Levetzow G, Feldhahn N, et al. The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia. Cancer Cell 2009; 16: 232\u201345.","journal-title":"Cancer Cell"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/aps20129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps20129","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps20129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:28:45Z","timestamp":1684412925000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/aps20129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,5]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["BFaps20129"],"URL":"https:\/\/doi.org\/10.1038\/aps.2012.9","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,5]]}}}